BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$2.31
-0.18 (-7.23%)
▼
5d:
-19.51%
30d:
-23.26%
90d:
-31.25%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jun 26, 2026
0d
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BDRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BDRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $2.31, which is considered oversold relative to its 30-day fair value range of $2.63 to $3.17.
Technical Outlook: Technically, BDRX is in a strong uptrend. Immediate support is located at $2.22, while resistance sits at $3.14. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: BDRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.10 (+337.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BDRX is in a strong uptrend. Immediate support is located at $2.22, while resistance sits at $3.14. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: BDRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.10 (+337.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.63 -
$3.17
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-7.2%)
- BULLISH: Trading 337.3% below Wall St target ($10.10)
- CAUTION: 5-day price weakness (-19.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.63 -
$3.17
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.22
Resistance Level
$3.14
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Wall Street Target
$10.10
(+337.3%)
Revenue Growth (YoY)
-64.1%
Share & Embed Analysis
Last updated: July 13, 2026 10:33 PM ET
Data refreshes hourly during market hours. Next update: 11:33 PM
Data refreshes hourly during market hours. Next update: 11:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
